top of page

A Trio of Patents Published

Remy Biosciences, Inc. is proud to announce the publication of three patent applications that redefine the landscape of drug delivery: the Reya Patch for menstrual cramps, a general pain relief patch, and a groundbreaking psilocybin therapy patch. Each solution employs our proprietary Remy Biosciences Biodermal Technology™, an innovative platform designed to maximize the efficacy and user experience of patch-based treatments.

 

The newly released Reya Patch is now available for purchase and offers significant relief from menstrual cramps. Reya was proven in a rigorous double-blind, placebo-controlled study to alleviate pain by up to 100%. For general pain relief, our second patch reduces the need for active pharmaceutical ingredients by 92% compared to traditional treatments, setting a new standard for efficiency and safety in pain management. Additionally, our psilocybin patch offers a novel approach to psilocybin therapy by eliminating gastrointestinal distress associated with oral intake, ensuring a smoother and more effective treatment experience.

At Remy Biosciences, our dedication to innovation is unyielding. We continue to strive to advance our intellectual property portfolio to meet and exceed modern healthcare needs. These latest patents underscore our commitment to pioneering the world's most advanced drug delivery solutions that prioritize patient safety, comfort, and effectiveness. As we move forward, Remy Biosciences remains steadfast in its mission to lead the next generation of drug delivery technology, pushing the boundaries of what's possible in medicine.

bottom of page